{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T13:09:19Z","timestamp":1788527359344,"version":"build-2803163510"},"reference-count":44,"publisher":"Oxford University Press (OUP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1093\/carcin\/bgs139","type":"journal-article","created":{"date-parts":[[2012,3,30]],"date-time":"2012-03-30T03:18:16Z","timestamp":1333077496000},"page":"1169-1177","source":"Crossref","is-referenced-by-count":23,"title":["EGF promotes neuroendocrine-like differentiation of prostate cancer cells in the presence of LY294002 through increased ErbB2 expression independent of the phosphatidylinositol 3-kinase-AKT pathway"],"prefix":"10.1093","volume":"33","author":[{"given":"M.Alicia","family":"Cort\u00e9s","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariel E.","family":"Cariaga-Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda V.T.","family":"Lobo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa M.","family":"Mart\u00edn Orozco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Moti\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.Javier","family":"Rodr\u00edguez-Ubreva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Angulo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"L\u00f3pez-Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bego\u00f1a","family":"Col\u00e1s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2012,3,29]]},"reference":[{"key":"key\n\t\t\t\t20170521005741_bib1","first-page":"1925","article-title":"Endocrine-induced regression of cancers","volume":"27","author":"Huggins","year":"1967","journal-title":"Cancer Res."},{"key":"key\n\t\t\t\t20170521005741_bib2","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1158\/1078-0432.CCR-10-0567","article-title":"New Strategies in metastatic prostate cancer: targeting the androgen receptor signaling pathway","volume":"17","author":"Attard","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"key\n\t\t\t\t20170521005741_bib3","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.eururo.2011.01.025","article-title":"EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer","volume":"59","author":"Mottet","year":"2011","journal-title":"Eur. Urol."},{"key":"key\n\t\t\t\t20170521005741_bib4","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/jcb.10771","article-title":"Steroid hormones, polypeptide growth factors, hormone refractory prostate cancer, and the neuroendocrine phenotype","volume":"91","author":"Evangelou","year":"2004","journal-title":"J. Cell. Biochem."},{"key":"key\n\t\t\t\t20170521005741_bib5","doi-asserted-by":"crossref","first-page":"S141","DOI":"10.1093\/annonc\/12.suppl_2.S141","article-title":"Neuroendocrine differentiation in human prostate cancer. Morphogenesis, proliferation and androgen receptor status","volume":"12","author":"Bonkhoff","year":"2001","journal-title":"Ann. Oncol."},{"key":"key\n\t\t\t\t20170521005741_bib6","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1159\/000283051","article-title":"Neuroendocrine cells in benign prostatic hyperplasia and prostatic carcinoma: effect of hormonal treatment","volume":"59","author":"Guate","year":"1997","journal-title":"Urol. Int."},{"key":"key\n\t\t\t\t20170521005741_bib7","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.eururo.2003.11.032","article-title":"Neuroendocrine differentiation in hormone refractory prostate cancer following androgen deprivation therapy","volume":"45","author":"Hirano","year":"2004","journal-title":"Eur. Urol."},{"key":"key\n\t\t\t\t20170521005741_bib8","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.eururo.2004.09.007","article-title":"Neuroendocrine differentiation in prostate cancer: implications for new treatment modalities","volume":"47","author":"Vashchenko","year":"2005","journal-title":"Eur. Urol."},{"key":"key\n\t\t\t\t20170521005741_bib9","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/(SICI)1097-0045(1998)8+<43::AID-PROS8>3.0.CO;2-H","article-title":"Evaluation and clinical value of neuroendocrine differentiation in human prostatic tumors","volume":"8","author":"Cussenot","year":"1998","journal-title":"Prostate Suppl."},{"key":"key\n\t\t\t\t20170521005741_bib10","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.humpath.2005.02.019","article-title":"Influence of neuroendocrine tumor cells on proliferation in prostatic carcinoma","volume":"36","author":"Grobholz","year":"2005","journal-title":"Hum. Pathol."},{"key":"key\n\t\t\t\t20170521005741_bib11","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1593\/neo.04379","article-title":"Phosphorylation of both EGFR and ErbB2 is a reliable predictor of prostate cancer cell proliferation in response to EGF","volume":"6","author":"El Sheikh","year":"2004","journal-title":"Neoplasia"},{"key":"key\n\t\t\t\t20170521005741_bib12","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1111\/j.1464-410X.2003.04503.x","article-title":"ErbB receptors: possible therapeutic targets in prostate cancer?","volume":"92","author":"Ratan","year":"2003","journal-title":"BJU Int."},{"key":"key\n\t\t\t\t20170521005741_bib13","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1093\/emboj\/19.13.3159","article-title":"The ErbB signaling network: receptor heterodimerization in development and cancer","volume":"19","author":"Olayioye","year":"2000","journal-title":"EMBO J."},{"key":"key\n\t\t\t\t20170521005741_bib14","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/35052073","article-title":"Untangling the ErbB signalling network","volume":"2","author":"Yarden","year":"2001","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"key\n\t\t\t\t20170521005741_bib15","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nrc1609","article-title":"ERBB receptors and cancer: the complexity of targeted inhibitors","volume":"5","author":"Hynes","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"key\n\t\t\t\t20170521005741_bib16","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1172\/JCI32278","article-title":"ErbB receptors: from oncogenes to targeted cancer therapies","volume":"117","author":"Zhang","year":"2007","journal-title":"J. Clin. Invest."},{"key":"key\n\t\t\t\t20170521005741_bib17","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1158\/1078-0432.CCR-09-2546","article-title":"Low level Her2 overexpression is associated with rapid tumor cell proliferation and poor prognosis in prostate cancer","volume":"16","author":"Minner","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"key\n\t\t\t\t20170521005741_bib18","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/6495","article-title":"A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2\/neu tyrosine kinase","volume":"5","author":"Craft","year":"1999","journal-title":"Nat. Med."},{"key":"key\n\t\t\t\t20170521005741_bib19","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.ccr.2004.09.031","article-title":"HER2\/neu kinase-dependent modulation of androgen receptor function through effects on DNA binding and stability","volume":"6","author":"Mellinghoff","year":"2004","journal-title":"Cancer Cell"},{"key":"key\n\t\t\t\t20170521005741_bib20","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.1073\/pnas.96.10.5458","article-title":"From HER2\/Neu signal cascade to androgen receptor and its coactivators: a novel pathway by induction of androgen target genes through MAP kinase in prostate cancer cells","volume":"96","author":"Yeh","year":"1999","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"key\n\t\t\t\t20170521005741_bib21","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1593\/neo.07337","article-title":"EGF prevents the neuroendocrine differentiation of LNCaP cells induced by serum deprivation: the modulator role of PI3K\/Akt","volume":"9","author":"Martin-Orozco","year":"2007","journal-title":"Neoplasia"},{"key":"key\n\t\t\t\t20170521005741_bib22","first-page":"2720","article-title":"Frequent inactivation of PTEN in prostate cancer cell lines and xenografts","volume":"58","author":"Vlietstra","year":"1998","journal-title":"Cancer Res."},{"key":"key\n\t\t\t\t20170521005741_bib23","first-page":"2891","article-title":"The phosphatidylinositol 3\u2032-kinase pathway is a dominant growth factor-activated cell survival pathway in LNCaP human prostate carcinoma cells","volume":"59","author":"Lin","year":"1999","journal-title":"Cancer Res."},{"key":"key\n\t\t\t\t20170521005741_bib24","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/pros.10245","article-title":"ErbB1 and prostate cancer: ErbB1 activity is essential for androgen-induced proliferation and protection from the apoptotic effects of LY294002","volume":"56","author":"T\u00f8rring","year":"2003","journal-title":"Prostate"},{"key":"key\n\t\t\t\t20170521005741_bib25","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/1471-2105-6-62","article-title":"A standard curve based method for relative real time PCR data processing","volume":"6","author":"Larionov","year":"2005","journal-title":"BMC Bioinformatics"},{"key":"key\n\t\t\t\t20170521005741_bib26","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0167-4889(01)00087-8","article-title":"Multipathways for transdifferentiation of human prostate cancer cells into neuroendocrine-like phenotype","volume":"1539","author":"Zelivianski","year":"2001","journal-title":"Biochim. Biophys. Acta"},{"key":"key\n\t\t\t\t20170521005741_bib27","doi-asserted-by":"crossref","first-page":"6264","DOI":"10.1158\/0008-5472.CAN-05-0152","article-title":"LY294002 and LY303511 sensitize tumor cells to drug-induced apoptosis via intracellular hydrogen peroxide production independent of the phosphoinositide 3-kinase-Akt pathway","volume":"65","author":"Poh","year":"2005","journal-title":"Cancer Res."},{"key":"key\n\t\t\t\t20170521005741_bib28","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1677\/erc.1.01043","article-title":"Androgen deprivation induces human prostate epithelial neuroendocrine differentiation of androgen-sensitive LNCaP cells","volume":"13","author":"Yuan","year":"2006","journal-title":"Endocr. Relat. Cancer"},{"key":"key\n\t\t\t\t20170521005741_bib29","first-page":"1130","article-title":"Coregulation of epidermal growth factor receptor\/human epidermal growth factor receptor 2 (HER2) levels and locations","volume":"63","author":"Hendriks","year":"2003","journal-title":"Cancer Res."},{"key":"key\n\t\t\t\t20170521005741_bib30","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1042\/BJ20061489","article-title":"Exploring the specificity of the PI3K family inhibitor LY294002","volume":"404","author":"Gharbi","year":"2007","journal-title":"Biochem. J."},{"key":"key\n\t\t\t\t20170521005741_bib31","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1042\/bj3510095","article-title":"Specificity and mechanism of action of some commonly used protein kinase inhibitors","volume":"351","author":"Davies","year":"2000","journal-title":"Biochem. J."},{"key":"key\n\t\t\t\t20170521005741_bib32","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1124\/jpet.105.083550","article-title":"LY303511 (2-piperazinyl-8-phenyl-4H-1-benzopyran-4-one) acts via phosphatidylinositol 3-kinase-independent pathways to inhibit cell proliferation via mammalian target of rapamycin (mTOR)- and non-mTOR-dependent mechanisms","volume":"314","author":"Kristof","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"key\n\t\t\t\t20170521005741_bib33","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1667\/RR1472.1","article-title":"NF-kappaB-mediated HER2 overexpression in radiation-adaptive resistance","volume":"171","author":"Cao","year":"2009","journal-title":"Radiat. Res."},{"key":"key\n\t\t\t\t20170521005741_bib34","doi-asserted-by":"crossref","first-page":"C82","DOI":"10.1152\/ajpcell.00486.2004","article-title":"Involvement of poly(ADP-ribose) polymerase 1 in ERBB2 expression in rheumatoid synovial cells","volume":"289","author":"Kitamura","year":"2005","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"key\n\t\t\t\t20170521005741_bib35","first-page":"1001","article-title":"Inhibition of c-erbB-2 oncogene expression by estrogens in human breast cancer cells","volume":"5","author":"Dati","year":"1990","journal-title":"Oncogene"},{"key":"key\n\t\t\t\t20170521005741_bib36","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.intimp.2006.01.007","article-title":"Enhancement of cytokine-mediated NF-[kappa]B activation by phosphatidylinositol 3-kinase inhibitors in monocytic cells","volume":"6","author":"Choi","year":"2006","journal-title":"Int. Immunopharmacol."},{"key":"key\n\t\t\t\t20170521005741_bib37","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0303-7207(02)00421-5","article-title":"The phosphatidylinositol 3-kinase inhibitor LY294002 binds the estrogen receptor and inhibits 17beta-estradiol-induced transcriptional activity of an estrogen sensitive reporter gene","volume":"200","author":"Pasapera Limon","year":"2003","journal-title":"Mol. Cell. Endocrinol."},{"key":"key\n\t\t\t\t20170521005741_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0303-7207(02)00089-8","article-title":"Estrogen receptor beta in the prostate","volume":"193","author":"Weihua","year":"2002","journal-title":"Mol. Cell. Endocrinol."},{"key":"key\n\t\t\t\t20170521005741_bib39","first-page":"3175","article-title":"Expression of estrogen receptor (ER)-alpha and ER-beta in normal and malignant prostatic epithelial cells: regulation by methylation and involvement in growth regulation","volume":"60","author":"Lau","year":"2000","journal-title":"Cancer Res."},{"key":"key\n\t\t\t\t20170521005741_bib40","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ejca.2003.08.010","article-title":"HER2 and COX2 expression in human prostate cancer","volume":"40","author":"Edwards","year":"2004","journal-title":"Eur. J. Cancer"},{"key":"key\n\t\t\t\t20170521005741_bib41","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/sj.bjc.6601200","article-title":"Different mechanisms are implicated in ERBB2 gene overexpression in breast and in other cancers","volume":"89","author":"Vernimmen","year":"2003","journal-title":"Br. J. Cancer"},{"key":"key\n\t\t\t\t20170521005741_bib42","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1093\/jnci\/92.23.1918","article-title":"Her-2-neu expression and progression toward androgen independence in human prostate cancer","volume":"92","author":"Signoretti","year":"2000","journal-title":"J. Natl. Cancer Inst."},{"key":"key\n\t\t\t\t20170521005741_bib43","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/30012","article-title":"Requirement of ErbB2 for signalling by interleukin-6 in prostate carcinoma cells","volume":"393","author":"Qiu","year":"1998","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170521005741_bib44","first-page":"880","article-title":"In vivo and in vitro ovarian carcinoma growth inhibition by a phosphatidylinositol 3-kinase inhibitor (LY294002)","volume":"6","author":"Hu","year":"2000","journal-title":"Clin. Cancer Res."}],"container-title":["Carcinogenesis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/carcin\/article-pdf\/33\/6\/1169\/17291232\/bgs139.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,24]],"date-time":"2017-08-24T13:21:45Z","timestamp":1503580905000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/carcin\/article-lookup\/doi\/10.1093\/carcin\/bgs139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,29]]},"references-count":44,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2012,3,29]]},"published-print":{"date-parts":[[2012,6]]}},"URL":"https:\/\/doi.org\/10.1093\/carcin\/bgs139","relation":{},"ISSN":["1460-2180","0143-3334"],"issn-type":[{"value":"1460-2180","type":"electronic"},{"value":"0143-3334","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3,29]]}}}